SELUTION DeNovo: Latest Evidence and Expert Insights On DeNovo And ISR Lesions
-
11m 19sPart 1 | Session 2 SELUTION DeNovo Study: Methods & Results
-
20m 37sPart 1 | Session 3 Discussion
-
27m 48sPart 2 | Session 1 A Guide to Non-Inferiority Margins
-
17m 40sPart 2 | Session 2 Sub-group Anaylsis - What Can We Expect
-
30m 6sPart 3 | Session 1 Score, Cut, NC or Just SC Balloon
-
14m 9sPart 3 | Session 2 Calcium Modification for DCB
-
17m 49sPart 4 | Session 1 Coronary Physiology
-
20m 9sPart 4 | Session 2 Intra-coronary Imaging
-
11m 12sPart 5 | Session 1 Small Diameter Vessels
-
14m 25sPart 5 | Session 2 Large Diameter Vessels
-
19m 3sPart 5 | Session 3 Bifurcations
-
10m 26sPart 5 | Session 4 Calcium
-
12m 57sPart 6 | Session 1 Acute Occlusions
-
17m 37sPart 6 | Session 2 Chronic Occlusions
-
12m 35sPart 7 | Session 1 Instent Restenosis
-
8m 35sPart 7 | Session 2 Left Main
-
45m 28sPart 8 | Session 1 Discussion
-
3m 13sPart 8 | Session 2 Summary of Key Findings, Wrap up & Close
Welcome to the World of Metal Free PCI
Faculty: Dr Peter O'Kane and Dr Simon Eccleshall
Panel: Dr Kalpa De Silva, Prof Tom Johnson and Dr Pitt Lim
This programme provides a practical, evidence-led review of drug-coated balloons in DeNovo coronary lesions. It examines the latest clinical data supporting DCB use and translates findings into decision-making for everyday PCI.
The content builds procedural confidence in DCB-based PCI, with emphasis on lesion preparation, intracoronary imaging techniques and optimal device delivery. Faculty also explore the main drivers of success, including drug formulation, balloon technology and procedural strategy.
Through expert-led discussion and real-world case studies, the programme addresses hybrid and stentless approaches for complex coronary anatomies. Participants will leave with clear, actionable insights to improve outcomes and standardise best practice.
Learning Objectives
- Analyse the latest clinical evidence supporting the use of drug-coated balloons in de novo coronary lesions
- Enhance procedural proficiency in DCB-based PCI, with focus on lesion preparation, intracoronary imaging techniques and optimal device delivery
- Identify key success drivers, including drug formulation, balloon technology and procedural strategy
- Apply hybrid and stentless approaches in complex coronary anatomies using real-world case insights
Target Audience
- Interventional cardiologists
- General cardiologists with an interest in PCI
- Cardiology fellows and trainees
- Catheterisation laboratory clinicians involved in coronary interventions
More from this programme
Part 1
Introduction
Part 2
Statistical Analysis of SELUTION DeNovo
Part 3
Methods: Practical Tools - Lesion Preparation
Part 4
Methods: Practical Tools - Lesion Assessment
Part 5
Results: Clinical Cases that Met inclusion Criteria
Part 6
Results: Clinical Cases That Met Exclusion Criteria
| 2 sessions | |
| Acute Occlusions | Watch now |
| Chronic Occlusions | Watch now |
Part 7
Evidence-based Strategies Recommended for Managing Challenging Coronary Lesions With DCB Where Stenting is Usually Considered?
| 2 sessions | |
| Instent Restenosis | Watch now |
| Left Main | Watch now |
Part 8
The Great Debate: The House That Believes That DCB PCI Should Become the Dominant Destination Therapy
Faculty Biographies
Peter O’Kane
Consultant Interventional Cardiologist
Dr Peter O'Kane has been Editor-in-Chief of Interventional Cardiology: Reviews, Research, Resources (ICR3) since July 2021.
Dr Peter O’Kane was appointed as a consultant interventional cardiologist at Royal Bournemouth Hospital in July 2007 and has performed more than 7000 PCI cases. He has extensive experience with coronary physiology and intra-coronary imaging to guide intervention and the many tools and techniques to manage bifurcations, calcification and chronic occlusions.
Dr O'Kane has given his permission to be contacted here.
Simon Eccleshall
Consultant Cardiologist
Dr Simon Eccleshall is a consultant cardiologist at Spire Norwich Hospital. Dr Eccleshall's cardiology practice and research are focused on the major health issue of coronary artery disease.
Kalpa De Silva
Consultant Interventional Cardiologist
Dr Kalpa De Silva has been a consultant interventional cardiologist at Guy's and St Thomas' NHS Foundation Trust since 2020. Previously he was a consultant interventional cardiologist at the Bristol Heart Institute, University Hospitals Bristol NHS Foundation Trust. He specialises in the management of coronary artery disease, looking after patients with chest pain, angina and those who have suffered heart attacks.
Tom Johnson
Consultant Cardiologist
Prof Johnson is fully trained in percutaneous coronary intervention and all aspects of general cardiology including hypertension, cardiovascular risk assessment, valvular heart disease, heart failure and arrhythmia.
He qualified from St Mary's Hospital (Imperial College, London) in 1998 and prior to commencing specialist training in the South West he undertook a period of research studying novel treatment strategies to prevent re-narrowing of stented coronaries and bypass grafts, culminating in the award of an MD. Additionally, he spent one year as Interventional Fellow at the world renowned Greenlane Cardiovascular Unit in New Zealand.
Pitt Lim
Cardiologist
Dr Lim completed his MBBS at the University of Newcastle-upon-Tyne Medical School in 1990. He then undertook higher specialist training cardiovascular medicine at Ninewell University Hospital and Medical School, Dundee from 1994 to 2000. During this period he completed his MD in hypertensive heart disease and contributed to the development of the “Dundee Step Test” and 20 peer reviewed publications.
Dr Lim was appointed as consultant in cardiology at St George’s Hospital in 2005. Since taking up his post at St George’s he has introduced radial approach coronary interventions to the Trust and is currently the clinical lead for cardiac intervention.